Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Horvatits

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|April 29, 2016
Coagulation parameters and major bleeding in critically ill patients with cirrhosisAndreas Drolz, Thomas Horvatits, Kevin Roedl, et al.
Annals of Hepatology|January 16, 2023
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severitySven Pischke, Anita Shiprov, Ulrike Peters, et al.
Gut|May 24, 2019
No link between male infertility and HEV genotype 3 infectionThomas Horvatits, Domenica Varwig-Janssen, Julian Schulze Zur Wiesch, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2016
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapyKaroline Rutter, Alexandra Etschmaier, Monika Ferlitsch, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Annals of Intensive Care|October 8, 2017
Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosisKevin Roedl, Christian Wallmüller, Andreas Drolz, et al.
Pathogens (Basel, Switzerland)|September 19, 2020
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV InfectionThomas Horvatits, Julian Schulze Zur Wiesch, Susanne Polywka, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
Scandinavian Journal of Gastroenterology|May 19, 2021
Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA eraFelix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|April 29, 2016
Coagulation parameters and major bleeding in critically ill patients with cirrhosisAndreas Drolz, Thomas Horvatits, Kevin Roedl, et al.
Annals of Hepatology|January 16, 2023
High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severitySven Pischke, Anita Shiprov, Ulrike Peters, et al.
Gut|May 24, 2019
No link between male infertility and HEV genotype 3 infectionThomas Horvatits, Domenica Varwig-Janssen, Julian Schulze Zur Wiesch, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2016
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapyKaroline Rutter, Alexandra Etschmaier, Monika Ferlitsch, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Annals of Intensive Care|October 8, 2017
Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosisKevin Roedl, Christian Wallmüller, Andreas Drolz, et al.
Pathogens (Basel, Switzerland)|September 19, 2020
Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV InfectionThomas Horvatits, Julian Schulze Zur Wiesch, Susanne Polywka, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
Scandinavian Journal of Gastroenterology|May 19, 2021
Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA eraFelix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, et al.
Pageof 6